Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ashland board authorizes quarterly dividend
-
Constellation Software Inc. Announces Results for the Second Quarter Ended June 30, 2025 and Declares Quarterly Dividend
-
Prospect Park Provides Corporate and Business Update
-
Lexin Reports Q2 2025 Financial Results: Revenue Hits RMB 3.59B with 15.6% QoQ Growth; Profit Rises for 5 Straight Quarters as Scenario-Based Transactions Surge to Spur Consumption
-
Aeromexico July 2025 Traffic Results
-
Rubicon Organics to Report Q2 2025 Results
-
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Holding(s) in Company
-
Fly Play hf.: Final Agenda and Board Proposals for the Shareholders’ Meeting
-
Purple Heart Homes Advocates for Veterans in Washington, D.C.
-
Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions
-
Director Chris Dela Cruz Announces Premiere of ‘Tiny Hearts’ Documentary on Pediatric Heart Surgery
-
Lithios Beverages Drives Excitement in NYC with Successful Sampling Events and Times Square Billboard
-
ChatAndBuild Debuts Worldwide, Powering AI App Creation in 40+ Languages as Industry M&A Heats Up
-
Parks! America, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results
-
Prize AI Technologies Launches $PRIZE Token Presale, Raises $100K+ Targeting $400B Arcade & Casino Market
-
JinGangShan Association Unveils SGD $43 Billion Sanctuaries in Indonesia and Malaysia, Forging a New Paradigm in Heritage and Asset Protection
-
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
-
Jeff Harsh named new Chief Operating Officer of Advantage Solutions Branded Services business segment
-
Paul Mueller Company Announces Quarterly Cash Dividend
-
CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR SECOND QUARTER 2025
-
Alamos Gold Announces Filing of Base Shelf Prospectus
-
Faraday Future Announces the Upcoming Special Meeting to Enable Rapid Execution of the Second Chapter of the Bridge Strategy and Adhere to Prudent Issuance Commitment Through Key Proposals
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR SECOND QUARTER 2025
-
Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme
-
#1 Best Selling Author, Robert J. Smith, MFA Unveils New Groundbreaking Business Guide
-
Barnes & Noble Education Receives NYSE Notice Regarding Delayed 10-K Filing
-
Barnes & Noble Education Receives NYSE Notice Regarding Delayed 10-K Filing
-
NI Holdings, Inc. Reports Results for Second Quarter Ended June 30, 2025
-
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
-
Westwood Holdings Group, Inc. Reports Second Quarter 2025 Results
-
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea
-
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Monroe Capital Corporation Schedules Second Quarter 2025 Earnings Release
-
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
-
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
-
Commerce to Present at Upcoming Investor Conference
-
Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
-
Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders
-
Amwell makes grant to new employees under inducement plan
-
Femasys Announces Second Quarter Financial Results for 2025
-
Phunware Reports Second Quarter 2025 Financial Results
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Heartland Physio Unveils The R.E.A.L. Recovery Experience for Singapore’s Active Professionals
-
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
-
UPDATE – Currenc Group's Founder and Executive Chairman to Convert $54.6 Million in Loans to Equity
-
UPDATE – Currenc Group's Founder and Executive Chairman to Convert $54.6 Million in Loans to Equity
-
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
-
IPG Chicago Facility Achieves TRUE Gold Zero Waste Certification
